Minimal antibody response in Imbokodo compels change of course for HIV vaccine research

Minimal antibody response in Imbokodo compels change of course for HIV vaccine research

It is 13 years now since RV144 became the only HIV vaccine ever to produce a (marginally) positive result in a large efficacy trial. And it’s eight years since aidsmap.com said that the vaccine’s results were “real – and could be made to work better.” An analysis presented yesterday at the International AIDS Conference of …

Minimal antibody response in Imbokodo compels change of course for HIV vaccine research Read More »